Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
30 April 2024 - P3244
Carbapenem-resistant Pseudomonas aeruginosa from patients, hospital environment, and water in Jakarta, Indonesia: distribution of antimicrobial resistance genes across domains
Selvi Nafisa Shahab, Jeff Gauthier, Irena Kukavica-Ibrulj, Marianne Potvin, Guillaume Quang Henri Nguyen, Yulia Rosa Saharman, Anis Karuniawati, Corné Klaassen, Juliëtte Severin, Roger C. Levesque
30 April 2024 - LB024
Exploring the efficacy of plasma exchange therapy in post-COVID-19 condition: a pilot randomised double-blind trial
Sergio España-Cueto, Cristina López, Cora Loste, Gemma Lladós-Bertran, José Ramón Santos, Gemma Dulsat, Anna García, Júlia Carabia, Águeda Ancochea, Anna Sánchez, Ivonne Graciela Parraga, Anna Chamorro, Alba San José, Elena Abad, José A. Muñoz, Anna Prats, Joao Pedro Carmezim, Cristian Tebe, M. Carmen Rodríguez, Roser Coll, Carla Estany, Jordi Puig, Bonaventura Clotet, Marta Massanella, Roger Paredes, Lourdes Mateu Prunonosa,
29 April 2024 - P2978
Personalised antifungal therapy through model-informed precision dosing of posaconazole
Anouk Jansen, Kim Snijdelaar, Ron Keizer, Isabel Spriet, Erwin Dreesen, Roger Brüggemann, Rob Ter Heine
29 April 2024 - P2969
Real-world evaluation of isavuconazole as prophylaxis and therapy for invasive fungal infections in paediatric patients with cancer
Janine Nijhuis, Anouk Jansen, Caroline Lindemans, Eline Muilwijk, Louis Bont, Wim Tissing, Roger Brüggemann, Tom Wolfs,
29 April 2024 - P3115
Persistence of viable but nonculturable Legionella pneumophila state in hospital water systems
Laura Gavaldà-Mestre, Noemí Párraga-Niño, Roger Cortès-Tarragó, Sara Quero, Marian Garcia-Núñez, Sara Sabaté, Dolors Ramirez-Tarruella
29 April 2024 - P2992
PK/PD target attainment with contemporary dosing of antifungal drugs. Outcomes from an international, multicentre pharmacokinetic study for screening antifungal exposure in intensive care units: The SAFE-ICU study
Jason A. Roberts, , Fekade Bruck Sime, Jeffrey Lipman, María Patricia Hernández-Mitre, João Pedro Baptista, Roger Brüggemann, Jai Darvall, Jan J. De Waele, George Dimopoulos, Jean-Yves Lefrant, Mohd Basri Mat Nor, Jordi Rello, Leonardo Seoane, Monica Slavin, Miia Valkonen, Mario Venditti, Wai Tat Wong, Markus Zeitlinger, Claire Roger
29 April 2024 - P2999
Model-informed identification of a weight-based fluconazole dosing strategy aiming for improved target attainment in critically ill patients
Luong Vuong, Omar Elkayal, Ruth Van Daele, Jan-Willem C. Alffenaar, Sophie Stocker, Jason Roberts, Yves Debaveye, Joost Wauters, Beatrijs Mertens, Jasper Boonstra, Indy Sandaradura, Roger Brüggemann, Jeroen Schouten, Raoul Bergner, Steven Buijk, Sebastian G. Wicha, Isabel Spriet, Erwin Dreesen
29 April 2024 - O1001
A randomised controlled non-inferiority trial of placebo vs macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study
Patrick M. Meyer Sauteur, Michelle Seiler, Romy Tilen, Ester Osuna, Margarete Von Wantoch, Christoph Aebi, Philipp Agyeman, Florence Barbey, Julia Anna Bielicki, Ludivine Coulon, Beate Deubzer, Alex Donas, Ulrich Heininger, Kristina Keitel, Henrik Köhler, Lisa Kottanattu, Roger Lauener, Anita Niederer, Klara Posfay Barbe, Maren Tomaske, Noémie Wagner, Petra Zimmermann, Franziska Zucol, Stefanie Von Felten, Christoph Berger,
28 April 2024 - P2494
Pulmonary penetration of high doses ceftobiprole administered by continuous infusion in critically ill patients with community-acquired pneumonia
Bernard Allaouchiche, Dominique Breilh, Jesse Butruille, Bob Occean, Arnaud Friggeri, Jean-Yves Lefrant, Claire Roger
28 April 2024 - P2501
Population pharmacokinetics and model-informed precision dosing of unbound teicoplanin in intensive care and hematology patients
Jaap Mouton, Nynke Jager, Eveline Wallenburg, Jeroen Schouten, Walter Van Der Velden, Rob Ter Heine, Roger Brüggemann
28 April 2024 - P2443
Development of an online tool for the management of drug-drug interactions with the novel anti-cytomegalovirus (CMV) agents letermovir and maribavir
David Burger, Laura Nijboer, Mira Ghobreyal, Johan Maertens, Nicole Blijlevens, Luuk Hilbrands, Marije Baas, Per Ljungman, Roger Brüggemann
28 April 2024 - E0763
Repurposing elvitegravir as a novel antibiotic against multidrug-resistant Gram-positive bacteria
Núria Martin-Vilardell, Elisa Rubio, Maria Piquet, Josep Maria Miró, Roger Paredes, Clara Ballesté-Delpierre, Jordi Vila Estapé,
28 April 2024 - P2457
Mechanism-based mathematical modelling predicts the effects of ciprofloxacin and meropenem on Pseudomonas aeruginosa with different resistance mechanisms in cases where PK/PD indices cannot
Alice Terrill, Kate Rogers, Carla López-Causapé, Wee Leng Lee, Roger L. Nation, Jiangning Song, Antonio Oliver, Cornelia B. Landersdorfer
28 April 2024 - E0548
Mechanism-based modelling approach to simultaneously characterise the effects of single and multiple resistance mechanisms on bacterial killing and resistance emergence of Pseudomonas aeruginosa in response to meropenem
Dominika Fuhs, Sara Cortés-Lara, Jessica Tait, Kate Rogers, Carla López-Causapé, Wee Leng Lee, Roger L. Nation, Antonio Oliver, Cornelia B. Landersdorfer
28 April 2024 - P2314
Ciprofloxacin-aztreonam combination provides synergistic killing against Pseudomonas aeruginosa PAO1 and isogenic strains showing AmpC or MexAB-OprM hyperproduction
Jessica Tait, Han B. Le, Cameron J. Nowell, Kate Rogers, Wee Leng Lee, Carla López-Causapé, Roger L. Nation, Antonio Oliver, Cornelia B. Landersdorfer
28 April 2024 - E0549
Ceftolozane/tazobactam and meropenem, in monotherapy and combination, against ST235 clone Pseudomonas aeruginosa isolates in the dynamic In vitro hollow-fibre infection model
Siobhonne Breen, Kate Rogers, Wee Leng Lee, Megan Faith, Jessica Tait, Alice Terrill, Carla López-Causapé, Roger L. Nation, Antonio Oliver, Cornelia B. Landersdorfer,
28 April 2024 - E0468
Photodynamic therapy with protoporphyrin IX precursors using artificial daylight improves skin antisepsis for orthopaedic surgeries
Tiziano Angelo Schweizer, Julia Shannon Wuermli, Julia Prinz, Maximilian Woelfle, Roger Marti, Hendrik Koliwer-Brandl, Reinhard Zbinden, Adrian Egli, Heinrich Walt, Laurence Imhof, Philipp Bosshard, Yvonne Achermann,
27 April 2024 - E0378
Improving the virus-associated pulmonary aspergillosis case definitions: a machine learning-based approach
Mehmet Ergün, Roger Brüggemann, Alexandre Alanio, Robbert Bentvelsen, Karin Van Dijk, Meltem Ergün, Katrien Lagrou, Jeroen Schouten, Joost Wauters, Lewis White, Paul Verweij,
27 April 2024 - P0563
Rates of long COVID-related symptoms and diagnoses in patients hospitalised with COVID-19 increased across variant eras
Mark Berry, Amanda M. Kong, Roger Paredes, Rohan Shah, Gina Brown, Rikisha Gupta, Robert L. Gottlieb, Lourdes Mateu, Mazin Abdelghany, Jason D. Goldman, Anand P. Chokkalingam
27 April 2024 - P0562
Increasing prevalence of comorbidities in patients hospitalised with COVID-19 across variant eras
Mark Berry, Amanda M. Kong, Roger Paredes, Rohan Shah, Gina Brown, Rikisha Gupta, Robert L. Gottlieb, Lourdes Mateu, Mazin Abdelghany, Florentin Scarlat, Jason D. Goldman, Anand P. Chokkalingam
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.